Knee Osteoarthritis Treatment Market Size, Share & Demand by 2034

Coverage: By Treatment Type (Non-Surgical Treatment, Surgical Treatment); End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00023789
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : May 26, 2026
Knee Osteoarthritis Treatment Market Size, Share & Demand by 2034
Report Date: May 26, 2026   |   Report Code: TIPRE00023789 Email: sales@theinsightpartners.com

2025 Market Size

US$ 6.82 Bn

Base year value

2034 Forecast

US$ 12.29 Bn

Projected by 2034

CAGR 2026-2034

7.64 %

Growth rate

Addressable Market

US$ 90.31 Bn

(2026-2034)

The Knee Osteoarthritis Treatment Market size is expected to reach US$ 12.29 Billion by 2034 from US$ 6.82 Billion in 2025. The market is estimated to record a CAGR of 7.64% from 2026 to 2034.

The report is segmented by Knee Osteoarthritis Treatment Market By Treatment Type (Non-Surgical Treatment, Surgical Treatment); End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Knee Osteoarthritis Treatment Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Knee Osteoarthritis Treatment Market Segmentation Treatment Type

  1. Non-Surgical Treatment
  2. Surgical Treatment

End-user

  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Specialty Clinics

Market Research Highlights

  • Global market for Knee Osteoarthritis Treatment was valued at US$ 6.82 Billion in 2025
  • Annual market size is expected to reach US$ 12.29 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 90.31 Billion
  • Market is anticipated to register a CAGR of 7.64% during the forecast period
  • The United States represents a key market, supported by Rising Prevalence of Knee Osteoarthritis, Aging Population, Advanced Solutions, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Favorable Regulatory Environment, Wearable Devices, Potential for New Treatment Paradigms are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including AVM Biotechnology, Bioventus, Flexion Therapeutics, Anika Therapeutics, Inc, OrthoTrophix, Inc., Pfizer Inc., Zimmer Biomet, Novartis AG, GlaxoSmithKline plc, Sanofi SA, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Knee Osteoarthritis Treatment Market: Strategic Insights

knee-osteoarthritis-treatment-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Knee Osteoarthritis Treatment Market Growth Drivers

  1. Rising Prevalence of Knee Osteoarthritis: One of the main causes is the rising prevalence of knee osteoarthritis (KOA), especially in the elderly population. The number of people with KOA is predicted to increase dramatically as the world's population ages, increasing the need for available treatment alternatives.
  2. Aging Population: Another important aspect affecting market growth is an aging population. The need for knee osteoarthritis (KOA) treatment that can deliver potential treatment option precisely and safely over long periods of time is increased by the fact that older persons often need specialized care and long-term medication administration.
  3. Advanced Solutions: For KOA patients, the use of digital health technologies like wearable technology and smartphone apps is improving illness management. Real-time monitoring of symptoms and activity levels is made possible by these technologies, which enhances patient participation and makes customized treatment programs possible. Access to healthcare services has also been made easier by telemedicine, which has grown in significance, particularly since COVID-19.

Knee Osteoarthritis Treatment Market Future Trends

  1. Technological Advancements: The management of KOA is changing as a result of the introduction of novel therapies, including as biologics and disease-modifying osteoarthritis medications (DMOADs). Because of their ability to restore damaged cartilage and lower inflammation, therapies like stem cell treatments, platelet-rich plasma (PRP) injections, and hyaluronic acid injections are becoming more popular. Both patients and healthcare professionals looking for better solutions find these developments appealing.
  2. Increased Investment in Research and Development: R&D for novel treatments that target KOA is becoming more and more important. Pharmaceutical firms are making significant investments in creating innovative therapeutic approaches that target osteoarthritis's underlying causes as well as its symptoms. This includes continuing research and clinical trials to find novel biologic treatments.
  3. Growing Awareness and Education: The need for efficient therapies is being driven by patients' and healthcare professionals' growing knowledge of knee osteoarthritis. More people are seeking medical attention early because to educational programs designed to increase awareness of KOA symptoms and available treatments. Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.

Knee Osteoarthritis Treatment Market Opportunities

  1. Favorable Regulatory Environment: New medicines that target KOA are being approved more quickly thanks to supportive regulatory regimes, especially in North America and Europe. A dedication to meeting unmet medical needs in this field is demonstrated by the FDA's fast-track designation for specific medicines.The market for knee osteoarthritis is expanding as a result of rising healthcare costs worldwide. Growing disposable incomes across different regions also assist patients' increased willingness to spend money on cutting-edge treatments that promise greater results.
  2. Wearable Devices: Wearable technology, including activity trackers and smartwatches, makes it possible to measure joint movement, gait, and levels of physical activity in real time. When necessary, early intervention can be facilitated by using the useful data these devices give to help healthcare providers customize treatment programs based on patient activity patterns and symptom changes.
  3. Potential for New Treatment Paradigms: With features like medication reminders, symptom tracking, and KOA education materials, mobile applications enable patients to better manage their disease. By allowing patients to log their symptoms and monitor their progress, these apps improve self-management and may result in increased participation in treatment regimens.

Knee Osteoarthritis Treatment Market Report Scope

Report Attribute Details
Market size in 2025 US$ 6.82 Billion
Market Size by 2034 US$ 12.29 Billion
Global CAGR (2026 - 2034) 7.64%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Treatment Type
  • Non-Surgical Treatment
  • Surgical Treatment
By End-user
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AVM Biotechnology
  • Bioventus
  • Flexion Therapeutics
  • Anika Therapeutics, Inc
  • OrthoTrophix, Inc.
  • Pfizer Inc.
  • Zimmer Biomet
  • Novartis AG
  • GlaxoSmithKline plc
  • Sanofi SA

Knee Osteoarthritis Treatment Market Players Density: Understanding Its Impact on Business Dynamics

The Knee Osteoarthritis Treatment Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

knee-osteoarthritis-treatment-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Knee Osteoarthritis Treatment Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Knee Osteoarthritis Treatment Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

High Competition and Price Pressure

Favorable Regulatory Environment

Europe region is expected to witness a high growth rate in terms of CAGR of 7.64% from 2026 to 2034

The Knee Osteoarthritis Treatment Market is estimated to witness a CAGR of 7.64% from 2026 to 2034

Rising Prevalence of Knee Osteoarthritis

Asia Pacific region is expected to witness the highest growth during the forecast period
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA